Both intermuscular fat and LVEF decline promote heart failure symptoms in cancer survivors

BACKGROUND: Approximately 20% of cancer survivors treated with chemotherapy experience worsening heart failure (HF) symptoms post-cancer treatment. While research has predominantly investigated the role of cardiotoxic treatments, much less attention has focused on other risk factors, such as adiposi...

Descripción completa

Detalles Bibliográficos
Autores principales: Reding, Kerryn W., O’Connell, Nathaniel S., D’Agostino, Ralph B., Hundley, William, Lucas, Alexander R., Ladd, Amy C., Jordan, Jennifer H., Heiston, Emily M., Ge, Yaorong, Hundley, W. Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105949/
https://www.ncbi.nlm.nih.gov/pubmed/33964981
http://dx.doi.org/10.1186/s40959-021-00102-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105949/
https://www.ncbi.nlm.nih.gov/pubmed/33964981
http://dx.doi.org/10.1186/s40959-021-00102-1

Ejemplares similares